series-c-plus
Stage
1
Investors
About
IgGenix is a biotechnology company that discovers and engineers allergen-specific antibodies to block and prevent allergic reactions, aiming to treat pediatric and adult patients with severe allergies.
Explore IgGenix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.